A study compared the levels of CCL2 in tumor tissue and adjacent healthy tissues from patients with breast, gastric, and ovarian cancer, and consistently observed an increased level of CCL2 in tumor samples [125]. The gene discussed is CCL2; the disease is ovarian carcinoma.